AARON MCJUNKINS: Open Payments
NPI 1023380953 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 112 payments from 12 companies in 2025. Trend: 2023 $278 · 2024 $602 · 2025 $1,931
Food & beverage: $1,931
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 25 | $401 |
| Vanda Pharmaceuticals Inc. | 12 | $286 |
| Indivior Inc. | 16 | $250 |
| Neurocrine BioSciences, Inc. | 12 | $240 |
| Alkermes, Inc. | 15 | $212 |
| ABBVIE INC. | 14 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
Products named: FANAPT, INVEGA SUSTENNA, SUBLOCADE, INGREZZA, ARISTADA, SPRAVATO, VRAYLAR, CAPLYTA.
Industry payments across OK — which companies pay providers there.
